Cargando…
Genetic Disruption of Myostatin Reduces the Development of Proatherogenic Dyslipidemia and Atherogenic Lesions In Ldlr Null Mice
OBJECTIVE: Insulin-resistant states, such as obesity and type 2 diabetes, contribute substantially to accelerated atherogenesis. Null mutations of myostatin (Mstn) are associated with increased muscle mass and decreased fat mass. In this study, we determined whether Mstn disruption could prevent the...
Autores principales: | Tu, Powen, Bhasin, Shalender, Hruz, Paul W., Herbst, Karen L., Castellani, Lawrence W., Hua, Ning, Hamilton, James A., Guo, Wen |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2712781/ https://www.ncbi.nlm.nih.gov/pubmed/19509018 http://dx.doi.org/10.2337/db09-0349 |
Ejemplares similares
-
AAV-Mediated Administration of Myostatin Pro-Peptide Mutant in Adult Ldlr Null Mice Reduces Diet-Induced Hepatosteatosis and Arteriosclerosis
por: Guo, Wen, et al.
Publicado: (2013) -
Atherogenic dyslipidemia
por: Manjunath, C. N., et al.
Publicado: (2013) -
Inhibition of in vitro and in vivo brown fat differentiation program by myostatin
por: Braga, Melissa, et al.
Publicado: (2013) -
Functional replacement of myostatin with GDF-11 in the germline of mice
por: Lee, Se-Jin, et al.
Publicado: (2022) -
The Proatherogenic Effect of Chronic Nitric Oxide Synthesis Inhibition in ApoE-Null Mice Is Dependent on the Presence of PPARα
por: Vechoropoulos, Michal, et al.
Publicado: (2014)